The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates

Platelets

Volumn 23, Issue 4, 2012, Pages 299-308

  Reikvam, Anne Grete ^a   Hustad, Steinar ^b   Reikvam, Håkon ^b   Apelseth, Torunn Oveland ^a   Nepstad, Ina ^a   Hervig, Tor Audun ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Bleeding; Platelet concentrate; Platelets; Selective serotonin reuptake inhibitors; Serotonin

Indexed keywords

CITALOPRAM; ESCITALOPRAM; GLYCOPROTEIN; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THROMBOCYTE CONCENTRATE; VENLAFAXINE;

ADULT; ARTICLE; BLOOD DONOR; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; THROMBOELASTOGRAPHY;

ADULT; BLOOD GAS ANALYSIS; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET MEMBRANE GLYCOPROTEINS; PLATELET TRANSFUSION; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; THROMBELASTOGRAPHY;

EID: 84862851119     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.618852     Document Type: Article

References (29)

1. Apelseth TO, Hervig T, Bruserud O. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia. Blood Rev 2011;25:113-122.
2. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study. Arch Intern Med 2003;163:59-64. (Pubitemid 36091601)
3. de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: Interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008;65:795-803. (Pubitemid 351957705)
4. van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study. BMJ 2001;323:655-658. (Pubitemid 32897004)
5. Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: A new look. Br J Clin Pharmacol 2008;66(1):76-81. (Pubitemid 351822152)
6. Wessinger S, Kaplan M, Choi L, Williams M, Lau C, Sharp L, Crowell MD, Keshavarzian A, Jones MP. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: A multicentre retrospective analysis. Aliment Pharmacol Ther 2006;23:937-944.
7. Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: A review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010;71:1565-1575.
8. van Haelst IM, Egberts TC, Doodeman HJ, Traast HS, Burger BJ, Kalkman CJ, van Klei WA. Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology 2010;112:631-636.
9. Movig KL, Janssen MW, de Waal Malefijt J, Kabel PJ, Leufkens HG, Egberts AC. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003;163:2354-2358. (Pubitemid 37310197)
10. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 2003;115:851-862. (Pubitemid 38058497)
11. Ross SB, Aperia B, Beck-Friis J, Jansa S, Wetterberg L, Aberg A. Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo. Psychopharmacology (Berl) 1980;67:1-7. (Pubitemid 10173713)
12. McCloskey DJ, Postolache TT, Vittone BJ, Nghiem KL, Monsale JL, Wesley RA, Rick ME. Selective serotonin reuptake inhibitors: Measurement of effect on platelet function. Transl Res 2008;151:168-172. (Pubitemid 351227436)
13. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000;68:435-442.
14. Hervig T, Volundardottir T, Bakken AM, Farstad M. Thrombin-induced serotonin release as an in vitro indicator of the functional integrity of stored platelets. Clin Chem 1990;36:28-31.
15. Hervig TA, Farstad M. Human blood platelet serotonin studied in vitro: Endogenous serotonin may stimulate thrombin-induced serotonin release in stored platelets. Platelets 1996;7:53-57.
16. Hervig TA, Farstad M, Vollset SE. Endogenous serotonin in human blood platelets: Factors that may influence reference values. Platelets 1996;7:47-52.
17. Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Storkson R, Hervig T. Thrombelastography. Transfus Apher Sci 2009;40:119-123.
18. Slichter SJ, Bolgiano D, Corson J, Jones MK, Christoffel T. Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or plasmalyte. Transfusion 2010;50:2199-2209.
19. Kotzailias N, Andonovski T, Dukic A, Serebruany VL, Jilma B. Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: A randomized, placebo-controlled, double-blind trial. J Clin Pharmacol 2006;46:468-475.
20. Abdelmalik N, Ruhe HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S, Buller HR, Schene AH, Kamphuisen PW. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost 2008;6:2168-2174.
21. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: Confusion or confounding? Am J Med 2006;119:719-727. (Pubitemid 44291626)
22. Serebruany VL, O'Connor CM, Gurbel PA. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am J Cardiol 2001;87:1398-1400. (Pubitemid 32523028)
23. Breddin HK. Can platelet aggregometry be standardized? Platelets 2005;16:151-158. (Pubitemid 40910903)
24. Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res 2001;43:453-462.
25. Musselman DL, Marzec UM, Manatunga A, Penna S, Reemsnyder A, Knight BT, Baron A, Hanson SR, Nemeroff CB. Platelet reactivity in depressed patients treated with paroxetine: Preliminary findings. Arch Gen Psychiatry 2000;57:875-882.
26. Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM. The association of depression with platelet activation: Evidence for a treatment effect. J Thromb Haemost 2009;7:573-581.
27. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986;78:130-137. (Pubitemid 16068191)
28. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996;93:11877-11882. (Pubitemid 26347217)
29. Hervig T, Flesland O, Svenningsen V, Bosnes V. Guidelines for transfusion in Norway. Transfus Apher Sci 2004; 31:181-184. (Pubitemid 39535513)